Immunovant shares owned by UBS Group
Historical chart of UBS Group investment in Immunovant
Tip: Access up to 7 years of quarterly data
All positions including Immunovant held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunovant by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $12M | 726k | 16.12 |
| 2025-06-30 | $11M | 695k | 16.00 |
| 2025-03-31 | $13M | 756k | 17.09 |
| 2024-12-31 | $15M | 615k | 24.77 |
| 2024-09-30 | $4.7M | 165k | 28.51 |
| 2024-06-30 | $3.8M | 143k | 26.40 |
| 2024-03-31 | $6.5M | 203k | 32.31 |
| 2023-12-31 | $6.5M | 155k | 42.13 |
| 2023-09-30 | $3.3M | 85k | 38.39 |
| 2023-06-30 | $1.7M | 92k | 18.97 |
| 2023-03-31 | $1.9M | 123k | 15.51 |
| 2022-12-31 | $2.7M | 154k | 17.75 |
| 2022-09-30 | $38k | 7.0k | 5.50 |
| 2022-06-30 | $9.1k | 2.3k | 4.00 |
| 2021-12-31 | $1.4M | 167k | 8.52 |
| 2021-09-30 | $423k | 49k | 8.68 |
| 2021-06-30 | $387k | 37k | 10.56 |
| 2021-03-31 | $1.3M | 83k | 16.04 |
| 2020-12-31 | $2.3M | 49k | 46.38 |
| 2020-09-30 | $30k | 839 | 35.76 |
| 2020-06-30 | $169k | 7.0k | 24.30 |
| 2020-03-31 | $37k | 2.4k | 15.70 |
| 2019-12-31 | $17k | 1.1k | 15.80 |